A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
基本信息
- 批准号:9885242
- 负责人:
- 金额:$ 63.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvisory CommitteesAffectAmericanAppointmentAwarenessBehaviorBenefits and RisksCancer EtiologyCatchment AreaCessation of lifeChestClinicColorectal CancerDataData AnalysesDecision AidDecision MakingDiseaseDoseEducationElectronic Health RecordElectronic MailEligibility DeterminationEnrollmentEnsureExerciseFutureGoalsGuidelinesHealthHealth PersonnelHealth TechnologyHealth systemIndividualIntentionInternetInterventionInterviewKnowledgeLungMalignant neoplasm of lungMalignant neoplasm of prostateMedicareMethodsModelingMorbidity - disease rateOnline SystemsOutcomeOutpatientsParticipantPatient CarePatient riskPatient-Centered CarePatientsPreventive servicePrimary Health CareProceduresProviderRandomizedRandomized Controlled TrialsRiskRisk FactorsScheduleScreening ResultScreening for cancerSmokerStructureSurveysSystemText MessagingTimeUnited StatesVisitX-Ray Computed Tomographycare providerschest computed tomographydemographicsdesigndigitalhigh riskinnovationlung basal segmentlung cancer screeningmalignant breast neoplasmmortalityoutreachoutreach programpatient portalpatient screeningprimary outcomeprogramsrecruitroutine screeningscreeningsecondary outcomeshared decision makingsocialtheories
项目摘要
Using annual chest CTs to screen for lung cancer, the leading cause of cancer death in the United States, can
reduce mortality by up to 20%; however, fewer than 4% of eligible Americans are screened. The US Preventive
Services Task Force endorses lung cancer screening (LCS) for high risk current and former smokers. At the
same time, LCS poses significant risks, such as false positives and invasive procedures. Accordingly,
guidelines recommend and Medicare requires that patients engage in a shared decision making visit prior to
screening. Unfortunately, primary care providers rarely discuss, and consequently patients rarely receive, LCS.
Patient, provider, and system barriers contribute to low LCS rates. Many patients are unaware that LCS exists,
that it is effective, or that they qualify for screening. The risks and benefits of LCS vary substantially according
to patients’ risk factors making general education about LCS difficult. Healthcare providers have poor
understanding of the screening criteria and lack the time and personalized information needed for shared
decision making discussions. Decision aids for LCS are a partial solution; they can increase patient
awareness, deliver personalized information, and help patients make a screening decision. However, they fail
to address many provider and system barriers. Our team has developed an innovative digital outreach strategy
called mPATH-Lung (mobile Patient Technology for Health – Lung) based on Social Ecological Theory and the
Integrative Model of Behavior. mPATH-Lung has multilevel functionality: it (a) queries the electronic health
record to identify potential screening candidates, (b) sends those individuals electronic invitations to visit a
web-based LCS decision aid that helps them make a screening decision concordant with their values, and (c)
empowers patients to electronically request an LCS clinic appointment for the mandated shared decision
making and subsequent screening. Electronic program summaries are sent to patients and providers, ensuring
shared decision making visits occur with informed participants. This project will determine the impact of
mPATH-Lung on patient decision making and receipt of LCS in a pragmatic randomized controlled trial using a
mixed methods design. The Specific Aims of the proposal are to: 1) Determine the effect of mPATH-Lung on
receipt of LCS in a pragmatic randomized-controlled trial of 1318 primary care patients in two large health
networks with a catchment area extending to 5 states; 2) Elucidate the drivers of patients’ LCS decisions and
screening behavior using a values clarification exercise and semi-structured interviews with at least 60 patients
selected to represent the spectrum of decision-behavior concordance; and 3) Explore implementation
outcomes that will impact the sustainability and dissemination of mPATH-Lung using program data, surveys,
and interviews. This project could decrease lung cancer morbidity and mortality by broadening the use of LCS
while simultaneously supporting patient-centered care. Importantly, our digital outreach design could have
broad applicability to other health conditions, expanding the impact of this proposal beyond LCS.
在美国,肺癌是导致癌症死亡的主要原因
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David P Miller其他文献
Color Doppler and two-dimensional echocardiographic determination of the mechanism of aortic regurgitation with surgical correlation.
彩色多普勒和二维超声心动图测定主动脉瓣关闭不全的机制与手术的相关性。
- DOI:
- 发表时间:
1996 - 期刊:
- 影响因子:6.5
- 作者:
G. Cohen;Carol I. Duffy;Allan L. Klein;David P Miller;D. Cosgrove;W. Stewart - 通讯作者:
W. Stewart
Long‐Term Protection from Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade with Percutaneous Coronary Intervention
经皮冠状动脉介入治疗短暂整合素 β3 阻断的随机试验对心肌缺血事件的长期保护
- DOI:
10.1097/00132586-199808000-00009 - 发表时间:
1998 - 期刊:
- 影响因子:0
- 作者:
E. Topol;J. Ferguson;H. Weisman;J. Tcheng;S. Ellis;N. Kleiman;R. Ivanhoe;Ann L. Wang;David P Miller;K. Anderson;R. Califf - 通讯作者:
R. Califf
Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Block
阿昔单抗对血管成形术并发症的减少很大程度上与基线病变形态无关。
- DOI:
10.1016/s0735-1097(98)00403-3 - 发表时间:
1998 - 期刊:
- 影响因子:24
- 作者:
Stephen G. Ellis;A. Lincoff;David P Miller;J. Tcheng;N. Kleiman;D. Kereiakes;R. Califf;E. Topol - 通讯作者:
E. Topol
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.
早期持续再灌注对既往心肌梗塞患者的益处(GUSTO-I 试验)。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:2.8
- 作者:
D. Brieger;K. Mak;H. White;N. Kleiman;David P Miller;A. Vahanian;A. Ross;R. Califf;E. Topol - 通讯作者:
E. Topol
Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.
在一项短期整合素 β3 阻断联合经皮冠状动脉介入治疗的随机试验中,可长期预防心肌缺血事件。
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:0
- 作者:
E. Topol;J. Ferguson;H. Weisman;J. Tcheng;Stephen G. Ellis;N. Kleiman;R. Ivanhoe;Ann L. Wang;David P Miller;K. Anderson;R. Califf - 通讯作者:
R. Califf
David P Miller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David P Miller', 18)}}的其他基金
A cloud-based digital health navigation program for colorectal cancer screening
基于云的结直肠癌筛查数字健康导航程序
- 批准号:
10697474 - 财政年份:2023
- 资助金额:
$ 63.54万 - 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
- 批准号:
10165873 - 财政年份:2020
- 资助金额:
$ 63.54万 - 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
- 批准号:
10551856 - 财政年份:2020
- 资助金额:
$ 63.54万 - 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
- 批准号:
10318171 - 财政年份:2020
- 资助金额:
$ 63.54万 - 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
- 批准号:
10062917 - 财政年份:2020
- 资助金额:
$ 63.54万 - 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
- 批准号:
9895633 - 财政年份:2018
- 资助金额:
$ 63.54万 - 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
- 批准号:
10116309 - 财政年份:2018
- 资助金额:
$ 63.54万 - 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
- 批准号:
10382400 - 财政年份:2018
- 资助金额:
$ 63.54万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 63.54万 - 项目类别:
Standard Grant